Drugs / GDC 695
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02952898 | Oct 2016 → Jul 2017 | actinic keratosis | Balmoral Medical company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GDC 695 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02952898 ↗ |
| Route | Topical | “GDC 695 gel applied topically as directed.” NCT02952898 ↗ |